About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: October 2009
Weekly Roundup – 10/30/09
It is Halloween Weekend. It is also the weekend to Fall Forward and reset the clocks. We are getting closer and closer to the big FDA Social Media Public Meeting on November 12 and 13. By coincidence, or perhaps not, … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup – 10/30/09
A Lesson in Reputation Management from the CDC in H1N1 Flu Vaccination
As the FDA struggles to re-furbish its image, highly tarnished during the last eight years, the CDC provides a lesson in reputation management in its response to the flu pandemic. By many accounts, trust in government is on the decline. … Continue reading
Posted in Uncategorized
Comments Off on A Lesson in Reputation Management from the CDC in H1N1 Flu Vaccination
The Spread and Utility of Sidewiki
The Sidewiki seed is spreading amongst the pharmaceutical industry. Sidewiki, you will recall, is a new tool brought to you by Google that allows any computer user on the Internet to go to any home page and insert a side … Continue reading
Posted in New and Social Media
9 Comments
FDA’s Plan for Risk Communication, Part 2
In a document released this Fall, the FDA laid out its Strategic Plan for Risk Communication. As noted in a posting last week, the plan states plainly the need for the FDA to move beyond its traditional parameters because of … Continue reading
Posted in Uncategorized
1 Comment
Weekly Roundup – 10/23/09
As always, Friday is welcomed. Barack Obama promised change and the trees are all complying. Fireplaces are once again being lit and comfort food like onion soup and mac and cheese is being contemplated more and more often by your's … Continue reading
Posted in Uncategorized
Comments Off on Weekly Roundup – 10/23/09